For clinical researchers, our “grade card” comes when the FDA inspects us. We all want to be told that we’ve operated in a compliant manner and that there were no findings. The alternative is to receive a Form FDA 483 (483) for significant deviations at the close of the inspection. When I got my first 483 as a research coordinator 18 years ago, I remember thinking to myself “I’m not going to let that happen again.” In my opinion, it was an indication that we had not delivered A+ work. Since the stakes are so high in this environment, and we’re asking patients to trust us to perform, it was a big wake up call for me.
Topics: IMARC Research, FDA, Form 483s

